Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
There are no as such competitors for BioXcel Therapeutics.
BioXcel Therapeutics has a consensus price target of $18.58.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $1.1719 last updated June 2, 2026 at 5:49 PM EDT.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.